Medicine, Health & Food

Medicine, Health & Food

Archive
Join as an Editor/Reviewer

Analysis of anti-body development against COVID-19 among persons who had experienced flu-like symptoms in Pagsanjan, Laguna, Philippines

Volume: 100  ,  Issue: 1 , May    Published Date: 10 May 2022
Publisher Name: IJRP
Views: 657  ,  Download: 331 , Pages: 99 - 119    
DOI: 10.47119/IJRP1001001520223114

Authors

# Author Name
1 Unaritz A. Alias
2 Elymar A. Pascual

Abstract

Several studies around the globe are still in process to prevent the transmission of disease-causing virus known as severe acute respiratory syndrome coronavirus 2 (SARS-Cov 2). It is known that flu and Covid-19 disease show similar symptoms that sometimes misinterpreted if not properly tested. SARS-Cov 2 antibody testing may reveal if the flu symptom experienced by a person could be a Covid-19 infection. The development of antibodies against SARS-CoV-2 could depend on age, gender, occupation and vaccination status. This study was conducted to assess the antibody response of Covid-19 in individuals with flu-like symptoms. The study was conducted between January and March 2022 during flu season. The respondents were 50 individuals who experienced flu-like symptoms in Pagsanjan, Laguna. The researchers utilized the descriptive quantitative method and used purposive sampling technique to gather data through questionnaire and antibody test. All consented volunteers underwent testing of antibodies using a rapid chromatographic immunoassay-based qualitative IgG/IgM kit. The data about age, gender, occupation, vaccination status and experienced symptoms were also collected. Frequency, percentage distribution and Chi-square were statistical treatment used in this study. It was found out that among age, gender, occupation and vaccination status, development of antibody against Covid-19 among persons who experienced flu-like symptoms are significantly dependent on occupation and vaccination status.

Keywords

  • Flu
  • COVID-19
  • SARS-CoV-2
  • Anti-body test
  • IgG and IgM